{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:54Z","timestamp":1786997934203,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"U.S. Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["U66 IP000169"],"award-info":[{"award-number":["U66 IP000169"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.vaccine.2010.10.026","type":"journal-article","created":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T04:20:28Z","timestamp":1288153228000},"page":"334-343","source":"Crossref","is-referenced-by-count":127,"title":["Economic analysis of the global polio eradication initiative"],"prefix":"10.1016","volume":"29","author":[{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.F.","family":"Wassilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Linkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bruce","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.10.026_bib0005","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pu.13.050192.001323","article-title":"Polio eradication from the Western Hemisphere","volume":"13","author":"de Quadros","year":"1992","journal-title":"Annual Reviews of Public Health"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0015","series-title":"Global eradication of poliomyelitis by the year 2000 (resolution 41.28)","author":"World Health Assembly","year":"1988"},{"issue":"9387 (September 13)","key":"10.1016\/j.vaccine.2010.10.026_bib0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(03)14337-1","article-title":"Global health goals: lessons from the worldwide effort to eradicate poliomyelitis","volume":"362","author":"Aylward","year":"2003","journal-title":"Lancet"},{"issue":"2\/3 (April\/May)","key":"10.1016\/j.vaccine.2010.10.026_bib0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1162\/154247603322391224","article-title":"Global disease eradication","volume":"1","author":"Barrett","year":"2003","journal-title":"Journal of the European Economic Association"},{"issue":"7 (July)","key":"10.1016\/j.vaccine.2010.10.026_bib0030","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of global policies for managing polio after eradication","volume":"98","author":"Thompson","year":"2008","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0035","series-title":"Poliomyelitis: mechanism for management of potential risks to eradication (resolution 61.1)","author":"World Health Assembly","year":"2008"},{"issue":"4 (December 18)","key":"10.1016\/j.vaccine.2010.10.026_bib0040","first-page":"35","article-title":"Policy decision options during the first 5 years following certification of polio eradication","volume":"5","author":"Sangrujee","year":"2003","journal-title":"Medscape General Medicine"},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.10.026_bib0045","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1539-6924.2006.00842.x","article-title":"The costs of polio risk management policies after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Analysis"},{"issue":"9570 (April 21)","key":"10.1016\/j.vaccine.2010.10.026_bib0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.026_bib0055","first-page":"1","article-title":"Is polio eradication in the Americas economically justified?","volume":"22","author":"Musgrove","year":"1988","journal-title":"Bulletin of the Pan American Health Organization"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0060","first-page":"35","article-title":"Global eradication of poliomyelitis: benefit-cost analysis","volume":"74","author":"Bart","year":"1996","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0065","series-title":"Global public goods for health: health economic and public health perspectives","first-page":"33","article-title":"Polio eradication","author":"Aylward","year":"2003"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0264-410X(02)00584-4","article-title":"Costs and benefits of polio eradication: a long-run global perspective","volume":"21","author":"Kahn","year":"2003","journal-title":"Vaccine"},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.10.026_bib0075","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","article-title":"Retrospective cost-effectiveness analyses for polio vaccination in the United States","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Analysis"},{"issue":"4 (August)","key":"10.1016\/j.vaccine.2010.10.026_bib0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1539-6924.2008.01078.x","article-title":"Uncertainty and sensitivity analyses of a decision analytic model for post-eradication polio risk management","volume":"28","author":"Duintjer Tebbens","year":"2008","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0360","unstructured":"World Health Organization. Global Polio Eradication Initiative - Strategic Plan 2010\u20132012; 2010. Geneva. Report No.: WHO\/Polio\/10.01."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0090","series-title":"Polio eradication initiative. Cessation of routine oral polio vaccine (OPV) use after global polio eradication. framework for national policy makers in OPV-using countries","author":"World Health Organization","year":"2005"},{"issue":"5748 (October 28)","key":"10.1016\/j.vaccine.2010.10.026_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.1115547","article-title":"OPV cessation \u2013 the final step to a \u201cpolio-free\u201d world","volume":"310","author":"Aylward","year":"2005","journal-title":"Science"},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.10.026_bib0100","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Analysis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.10.026_bib0105","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"The Medscape Journal of Medicine"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0110","unstructured":"UN Population Division. World population prospects population database: the 2008 revision population database; 2010 [cited 2010 January 4]. Available from: http:\/\/esa.un.org\/unpp\/."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0115","unstructured":"World Bank. Country classification; 2009 [cited 2009 June 13]. Available from: http:\/\/go.worldbank.org\/K2CKM78CC0."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0120","series-title":"Polio eradication initiative external funds database","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0125","unstructured":"World Health Organization. WHO\/UNICEF estimated coverage time series; 2009 October [cited 2010 February 15]. Available from: http:\/\/www.who.int\/entity\/immunization_monitoring\/data\/coverage_estimates_series.xls."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0130","unstructured":"World Health Organization. Incidence series; 2009, December 21 [cited 2010 February 15]. Available from: http:\/\/www.who.int\/entity\/immunization_monitoring\/data\/incidence_series.xls."},{"issue":"4 (August)","key":"10.1016\/j.vaccine.2010.10.026_bib0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"American Journal of Epidemiology"},{"issue":"7 (July)","key":"10.1016\/j.vaccine.2010.10.026_bib0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2471\/BLT.08.053819","article-title":"WHO and UNICEF estimates of national infant immunization coverage: methods and processes","volume":"87","author":"Burton","year":"2009","journal-title":"Bulletin of the World Health Organization"},{"issue":"8","key":"10.1016\/j.vaccine.2010.10.026_bib0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/oxfordjournals.aje.a008820","article-title":"Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?","volume":"143","author":"Eichner","year":"1996","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0150","unstructured":"World Health Organization. AFP case count; 2010 February 12 [cited 2010 February 15]. Available from: http:\/\/www.who.int\/vaccines\/immunization_monitoring\/en\/diseases\/poliomyelitis\/case_count.cfm."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(94)92472-4","article-title":"Paralytic poliomyelitis: seasoned strategies, disappearing disease","volume":"343","author":"Hull","year":"1994","journal-title":"Lancet"},{"issue":"43 (30 October)","key":"10.1016\/j.vaccine.2010.10.026_bib0160","first-page":"337","article-title":"Poliomyelitis 1980 \u2013 part 2","volume":"56","author":"World Health Organization","year":"1981","journal-title":"Weekly Epidemiological Record"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0165","unstructured":"World Health Organization. Circulating vaccine-derived poliovirus, 2000\u20132009; 2010 February 2 [cited 2010 February 15]. Available from: http:\/\/www.polioeradication.org\/content\/general\/cvdpv_count.pdf."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0170","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0175","series-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0180","unstructured":"Bureau of Labor Statistics, U.S. Department of Labor. Consumer price index. June 17; 2009 [cited 2009 July 2]. Available from: ftp:\/\/ftp.bls.gov\/pub\/special.requests\/cpi\/cpiai.txt."},{"key":"10.1016\/j.vaccine.2010.10.026_bib0185","series-title":"Details of projected GPEI external resource requirements 2009\u20132013 as of June 2009","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0190","unstructured":"World Health Organization. Global polio eradication initiative \u2013 financial resource requirements 2010\u20132012 as of February 2010. Geneva; 2010. Report No.: WHO\/POLIO\/10.01."},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.10.026_bib0195","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1539-6924.2006.00845.x","article-title":"Global surveillance and the value of information: the case of the global polio laboratory network","volume":"26","author":"de Gourville","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0200","series-title":"WHO global action plan to minimize poliovirus facility-associated risk in the post-eradication\/post-OPV era","author":"World Health Organization","year":"2007"},{"issue":"26 (June 11)","key":"10.1016\/j.vaccine.2010.10.026_bib0205","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2010.04.001","article-title":"Optimal vaccine stockpile design for an eradicated disease: application to polio","volume":"28","author":"Duintjer Tebbens","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.10.026_bib0210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1996.03540120045032","article-title":"Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule","volume":"276","author":"Miller","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0215","unstructured":"Ministry of Health, Brazil. Mem\u00f3ria sobre estimativa de custos dos casos de poliomielite no Brasil em 1982. Brasilia; 1984."},{"issue":"5 (July)","key":"10.1016\/j.vaccine.2010.10.026_bib0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1467-842X.2001.tb00648.x","article-title":"Cost-effectiveness of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia","volume":"25","author":"Tucker","year":"2001","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0225","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2006.05.032","article-title":"The cost-effectiveness of alternative polio immunization policies in South Africa","volume":"24","author":"Griffiths","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0230","series-title":"Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health","author":"World Health Organization Commission on Macroeconomics and Health","year":"2001"},{"issue":"1 (December 19)","key":"10.1016\/j.vaccine.2010.10.026_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"WHO-CHOICE. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Effectiveness and Resource Allocation"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0240","series-title":"The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020","author":"Murray","year":"1996"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2010.10.026_bib0245","first-page":"1526","article-title":"Childhood mortality impact and costs of integrating vitamin A supplementation into immunization campaigns","volume":"90","author":"Ching","year":"2000","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.026_bib0250","first-page":"305","article-title":"Polio as a platform: using national immunization days to deliver vitamin A supplements","volume":"78","author":"Goodman","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0255","unstructured":"Gacic-Dobo M. IVB SIA database as of 21 December, 2009. Geneva; 2009."},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.026_bib0260","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2105\/AJPH.87.6.922","article-title":"Ethical Dilemmuas in current planning for polio eradication","volume":"87","author":"Taylor","year":"1997","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0265","series-title":"The impact of the expanded programme on immunization and the polio eradication initiative on health systems in the Americas","author":"Taylor Commission","year":"1995"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.026_bib0270","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2105\/AJPH.87.6.913","article-title":"Ethical dilemmas in worldwide polio eradication programs","volume":"87","author":"Sutter","year":"1997","journal-title":"American Journal of Public Health"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.10.026_bib0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2105\/AJPH.92.1.19","article-title":"Impact of targeted programs on health systems: a case study of the polio eradication initiative","volume":"92","author":"Loevinsohn","year":"2002","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.026_bib0280","first-page":"285","article-title":"Disease eradication as a public health strategy: a case study of poliomyelitis eradication","volume":"78","author":"Aylward","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0285","series-title":"The global epidemiology of infectious diseases","first-page":"111","article-title":"Poliomyelitis","author":"Shibuya","year":"2004"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.026_bib0290","first-page":"80","article-title":"Worldwide status of poliomyelitis in 1986, 1987 and 1988, and plans for its global eradication by the year 2000","volume":"43","author":"Robertson","year":"1990","journal-title":"World Health Statistics Quarterly"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0295","unstructured":"World Health Organization. Expanded Programme on Immunization: EPI global overview. Geneva; 1986. Report No.: EPI\/GAG\/86\/WP.1."},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.026_bib0300","first-page":"535","article-title":"Immunizing the children of the world: progress and prospects","volume":"66","author":"Henderson","year":"1988","journal-title":"Bulletin of the World Health Organization"},{"issue":"6519","key":"10.1016\/j.vaccine.2010.10.026_bib0305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.292.6519.531","article-title":"Strategy for rapid elimination and continuing control of poliomyelitis and other vaccine preventable diseases of children in developing countries","volume":"292","author":"Sabin","year":"1986","journal-title":"British Medical Journal (Clinical Research Edition)"},{"issue":"4 Pt 2","key":"10.1016\/j.vaccine.2010.10.026_bib0310","first-page":"475","article-title":"Progress towards the eradication of poliomyelitis globally and in Africa, January 2000","volume":"59","author":"Tangermann","year":"1999","journal-title":"M\u00e9decine tropicale: revue du Corps de sant\u00e9 colonial"},{"issue":"29 (July 27)","key":"10.1016\/j.vaccine.2010.10.026_bib0315","first-page":"620","article-title":"Global progress toward laboratory containment of wild polioviruses, June 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"34 (November)","key":"10.1016\/j.vaccine.2010.10.026_bib0320","first-page":"72","article-title":"Endgame issues for the global polio eradication initiative","volume":"19","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"18 (May 9)","key":"10.1016\/j.vaccine.2010.10.026_bib0325","first-page":"489","article-title":"Progress toward interruption of wild poliovirus transmission \u2013 worldwide, January 2007\u2013April 2008","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.10.026_bib0330","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1539-6924.2006.00840.x","article-title":"Risk management in a polio-free world","volume":"26","author":"Aylward","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0335","unstructured":"World Health Organization ROfE. WHO epidemiological brief: Tajikistan polio outbreak and regional response; 2010 [cited 2010 July 27]. Available from: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0019\/118342\/EPI_TJK_Issue3.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.026_bib0340","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/0272-4332.00070","article-title":"Validating benefit and cost estimates: the case of airbag regulation","volume":"22","author":"Thompson","year":"2002","journal-title":"Risk Analysis"},{"issue":"28 (July 10)","key":"10.1016\/j.vaccine.2010.10.026_bib0345","first-page":"281","article-title":"Progress towards poliomyelitis eradication in India, January 2007\u2013May 2009","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Weekly Epidemiological Record"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.10.026_bib0350","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1093\/infdis\/175.Supplement_1.S286","article-title":"The biologic principles of poliovirus eradication","volume":"175","author":"Dowdle","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2010.10.026_bib0355","unstructured":"World Bank. World development indicators data query; 2009 [cited 2009 July 8]. Available from: http:\/\/devdata.worldbank.org\/data-query\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T17:05:30Z","timestamp":1711904730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10014957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0264410X10014957"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}